Celerion | Phoenix Celerion CPU
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Celerion
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Active trials
This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
This is a study to determine the safety of CDX-622 in healthy participants.
The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared...
The purposes of this Phase 1 study of EDG-15400 are to:1. Learn about the safety of EDG-15400 after single and multiple doses in healthy adults2. Lea...
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of BMS-986419 (Part 1) and the effects of multiple doses o...
The purpose of the study is to assess the effects of multiple doses of itraconazole (a strong CYP3A4 inhibitor) on single dose PK of casdatifan in he...
A Phase 2a study of PORT-77 in adults with erythropoietic protoporphyria (EPP)
This is a 4-part study. Part A will be a randomized, double-blind, placebo-controlled investigation of single ascending doses (SAD) to assess the saf...
A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation...
Trial sponsors
Clinical trials
Research sites
Resources
Legal